Evelo Biosciences, Inc.

OTCPK:EVLO Voorraadrapport

Marktkapitalisatie: US$7.6k

Evelo Biosciences Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijn4.8yrs
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Is Evelo Biosciences (NASDAQ:EVLO) Using Debt In A Risky Way?

Aug 18
Is Evelo Biosciences (NASDAQ:EVLO) Using Debt In A Risky Way?

Evelo Biosciences GAAP EPS of -$0.40 beats by $0.03

Aug 11

Marella Thorell is the new finance chief of Evelo Biosciences

Jul 18

Evelo Biosciences: Hope After Dilution?

Jun 06

Evelo Biosciences (NASDAQ:EVLO) Has Debt But No Earnings; Should You Worry?

Mar 21
Evelo Biosciences (NASDAQ:EVLO) Has Debt But No Earnings; Should You Worry?

Is Evelo Biosciences (NASDAQ:EVLO) Weighed On By Its Debt Load?

Sep 25
Is Evelo Biosciences (NASDAQ:EVLO) Weighed On By Its Debt Load?

What Type Of Shareholders Make Up Evelo Biosciences, Inc.'s (NASDAQ:EVLO) Share Registry?

Mar 11
What Type Of Shareholders Make Up Evelo Biosciences, Inc.'s (NASDAQ:EVLO) Share Registry?

Evelo Bio secures ~$67.5M capital raise

Jan 29

Evelo Biosciences expands EDP1815 mid-stage trial to atopic dermatitis

Jan 07

Trade Alert: The Independent Chairman Of Evelo Biosciences, Inc. (NASDAQ:EVLO), David Epstein, Has Just Spent US$51k Buying 77% More Shares

Dec 15
Trade Alert: The Independent Chairman Of Evelo Biosciences, Inc. (NASDAQ:EVLO), David Epstein, Has Just Spent US$51k Buying 77% More Shares

Do Institutions Own Evelo Biosciences, Inc. (NASDAQ:EVLO) Shares?

Dec 11
Do Institutions Own Evelo Biosciences, Inc. (NASDAQ:EVLO) Shares?

Evelo Biosciences identifies new lead oncology candidate

Dec 09

Evelo Bio's EDP1815 completes enrollment targeting interim data in mid-stage psoriasis study

Dec 03

Evelo Biosciences EPS beats by $0.04

Oct 29

CEO

Evelo Biosciences heeft geen CEO, of we hebben geen gegevens over hen.

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Craig Jalbert
Presidentless than a yeargeen gegevensgeen gegevens
Chun Zhang
Chief Technical Operations & Quality Officer4.8yrsgeen gegevensgeen gegevens
Mark Bodmer
Chief Scientific Officer and President of Research & Development8.6yrsUS$1.15m0.14%
$ 10.3
Jessica Cotrone
VP & Head of Communicationsno datageen gegevensgeen gegevens
Leslie Wardwell-Scott
VP and Head of Corporate Development & Strategic Integration2.4yrsgeen gegevensgeen gegevens
Andrea Itano
Head of Research4.8yrsgeen gegevensgeen gegevens
Duncan McHale
Chief Medical Officer6.8yrsUS$1.23m0.089%
$ 6.8
Douglas Maslin
Senior Director & Immunology Clinical Leadno datageen gegevensgeen gegevens

4.8yrs

Gemiddelde duur

62yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van EVLO wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).